FilingsTodayP&K Skin Research Center
At a glance
P&K Skin Research Center filed 14 disclosures in the last 12 months.
Revenue for 2025 was ₩22.8B, up 27.7% on 2024. Operating margin was 17.3% against 14.5% a year earlier. Debt was 8% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩12.8B and operating profit of ₩2.5B.
The 2025 annual report lists 121 employees with an average tenure of 2.6 years and average pay of ₩43.9M, #1676 of 1,829 listed companies by average pay. Its 5 directors and auditors were paid ₩173M each on average. It paid ₩50 per common share in cash dividends, against ₩40 a year earlier (+25%). 대봉엘에스(주) and related parties held 59.41% at year end.
From the 2025 annual report
Staff: 121 (23 men, 98 women), of whom 14 on fixed-term contracts. Total pay for the year: ₩5.3B. Directors and auditors: 5, paid ₩863M in total.
Dividends (common shares)
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash dividend per share | ₩50 | ₩40 | ₩30 |
| Payout ratio | 27% | 16.8% | 14.8% |
| Yield (as filed) | 1.98% | 1.85% | 1.21% |
| Total cash dividends | ₩1.3B | ₩977M | ₩715M |
Largest shareholder
대봉엘에스(주) holds 55.91%; with 4 related parties the group holds 59.41% of common shares at year end.
Auditor: 한영회계법인 · opinion: Unqualified.
Source: 2025 annual business report (DART). How figures are combined
Financial summary
Key filings
No key filings in the last 12 months.
Other filings
Links open the original filing on DART, in Korean.